Pregnancy does not adversely impact diagnostic tests for HTLV-1/2 infection

PLoS Negl Trop Dis. 2019 Sep 12;13(9):e0007736. doi: 10.1371/journal.pntd.0007736. eCollection 2019 Sep.

Abstract

Mother-to-child-transmission (MTCT) of human T-cell lymphotropic virus type-1(HTLV-1) contributes disproportionately to the burden of HTLV-1 associated diseases. All preventive measures to avoid MTCT rely on the identification of infected mothers. However, the impact of pregnancy on HTLV-1 diagnosis has not been clearly assessed. Paired samples from 21 HTLV-1 infected women taken during pregnancy and while not pregnant were analysed by CMIA and PCR. The signal-to-cut-off values (S/CO) were higher during pregnancy than in the paired non-pregnant samples. HTLV-1 proviral load did not alter significantly by pregnant state. S/CO positively correlated with HTLV proviral load. Pregnancy does not impair the diagnosis of HTLV-1/2, by either immunological (CMIA) or molecular (qPCR/nPCR) tests.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • HTLV-I Infections / diagnosis*
  • HTLV-I Infections / virology
  • HTLV-II Infections / diagnosis*
  • HTLV-II Infections / virology
  • Human T-lymphotropic virus 1 / isolation & purification*
  • Human T-lymphotropic virus 2 / isolation & purification*
  • Humans
  • Immunoassay / methods
  • Pregnancy
  • Pregnancy Complications / virology*
  • Real-Time Polymerase Chain Reaction / methods
  • Viral Load